<!DOCTYPE html>
<!-- saved from url=(0073)https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7 -->
<html lang="en" dir="ltr"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
        
        <title>Inclusion body myositis | Paper to HTML | Allen Institute for AI</title>
        <meta name="viewport" content="width=device-width,initial-scale=1,shrink-to-fit=no">
        <link rel="stylesheet" href="./7617187_files/a11y.css">
        <link rel="stylesheet" href="./7617187_files/style.css">
        <link rel="icon" href="https://papertohtml.org/static/favicon.ico">
        <meta name="twitter:card" content="summary_large_image">
        <meta name="twitter:site" content="@SemanticScholar">
        <meta name="twitter:image" content="https://papertohtml.org/static/social.png">
        <meta name="twitter:title" content="Inclusion body myositis | Paper to HTML | Allen Institute for AI">
        <meta name="twitter:description" content="Convert scientific papers to accessible HTML on demand. Paper to HTML is a free service of the non-profit AI2.">
    <style type="text/css" id="hs-form-style05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6">.fn-date-picker.pika-single{z-index:9999;display:block;position:relative;color:#333;background:#fff;border:1px solid #ccc;border-bottom-color:#bbb;font-family:Helvetica Neue,Helvetica,Arial,sans-serif;*zoom:1}.fn-date-picker.pika-single.is-hidden{display:none}.fn-date-picker.pika-single.is-bound{position:absolute;box-shadow:0 5px 15px -5px rgba(0,0,0,.5)}.fn-date-picker.pika-single:after,.fn-date-picker.pika-single:before{content:" ";display:table}.fn-date-picker.pika-single:after{clear:both}.fn-date-picker .pika-lendar{float:left;width:240px;margin:8px}.fn-date-picker .pika-title{position:relative;text-align:center}.fn-date-picker .pika-title select{cursor:pointer;position:absolute;z-index:9998;margin:0;left:0;top:5px;filter:alpha(opacity=0);opacity:0}.fn-date-picker .pika-label{display:inline-block;*display:inline;position:relative;z-index:9999;overflow:hidden;margin:0;padding:5px 3px;font-size:14px;line-height:20px;font-weight:700;background-color:#fff}.fn-date-picker .pika-next,.fn-date-picker .pika-prev{display:block;cursor:pointer;position:relative;outline:none;border:0;padding:0;width:20px;height:30px;text-indent:20px;white-space:nowrap;overflow:hidden;background-color:transparent;background-position:50%;background-repeat:no-repeat;background-size:75% 75%;opacity:.5;*position:absolute;*top:0}.fn-date-picker .pika-next:hover,.fn-date-picker .pika-prev:hover{opacity:1}.fn-date-picker .pika-next.is-disabled,.fn-date-picker .pika-prev.is-disabled{cursor:default;opacity:.2}.fn-date-picker .is-rtl .pika-next,.fn-date-picker .pika-prev{float:left;background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAAeCAYAAAAsEj5rAAAAUklEQVR42u3VMQoAIBADQf8Pgj+OD9hG2CtONJB2ymQkKe0HbwAP0xucDiQWARITIDEBEnMgMQ8S8+AqBIl6kKgHiXqQqAeJepBo/z38J/U0uAHlaBkBl9I4GwAAAABJRU5ErkJggg==");*left:0}.fn-date-picker .is-rtl .pika-prev,.fn-date-picker .pika-next{float:right;background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAAeCAYAAAAsEj5rAAAAU0lEQVR42u3VOwoAMAgE0dwfAnNjU26bYkBCFGwfiL9VVWoO+BJ4Gf3gtsEKKoFBNTCoCAYVwaAiGNQGMUHMkjGbgjk2mIONuXo0nC8XnCf1JXgArVIZAQh5TKYAAAAASUVORK5CYII=");*right:0}.fn-date-picker .pika-select{display:inline-block;*display:inline}.fn-date-picker .pika-table{width:100%;border-collapse:collapse;border-spacing:0;border:0}.fn-date-picker .pika-table td,.fn-date-picker .pika-table th{width:14.285714285714286%;padding:0}.fn-date-picker .pika-table th{color:#999;font-size:12px;line-height:25px;font-weight:700;text-align:center}.fn-date-picker .pika-table abbr{border-bottom:none;cursor:help}.fn-date-picker .pika-button{cursor:pointer;display:block;-moz-box-sizing:border-box;box-sizing:border-box;outline:none;border:0;margin:0;width:100%;padding:5px;color:#666;font-size:12px;line-height:15px;text-align:right;background:#f5f5f5}.fn-date-picker .pika-button:hover{color:#fff!important;background:#ff8000!important;box-shadow:none!important;border-radius:3px!important}.fn-date-picker .is-today .pika-button{color:#3af;font-weight:700}.fn-date-picker .is-selected .pika-button{color:#fff;font-weight:700;background:#3af;box-shadow:inset 0 1px 3px #178fe5;border-radius:3px}.fn-date-picker .is-disabled .pika-button{pointer-events:none;cursor:default;color:#999;opacity:.3}.fn-date-picker .pika-week{font-size:11px;color:#999} .hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 .inputs-list.inline-list li{vertical-align:top;display:inline-block;word-wrap:break-word;padding-right:16px}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 .inputs-list.inline-list li:after{clear:both}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 .inputs-list.inline-list li input{float:left}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 .inputs-list.inline-list.inline-list-2 li{width:50%}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 .inputs-list.inline-list.inline-list-2 li:nth-child(2n){padding-right:0}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 .inputs-list.inline-list.inline-list-3 li{width:33%}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 .inputs-list.inline-list.inline-list-3 li:nth-child(3n){width:34%;padding-right:0}.hs-fieldtype-intl-phone.hs-input{padding:0;background:none;border:none;height:auto}.hs-fieldtype-intl-phone.hs-input:after{clear:both;content:" ";display:table}.hs-fieldtype-intl-phone.hs-input .hs-input{margin-bottom:0}.hs-fieldtype-intl-phone.hs-input input{width:68%!important;float:right}.hs-fieldtype-intl-phone.hs-input select{float:left;width:30%!important}@media (max-device-width:480px) and (min-device-width:320px),(max-width:400px){.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6>.hs-phone>.input>.hs-fieldtype-intl-phone.hs-input>input.hs-input{width:68%!important}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6>.hs-phone>.input>.hs-fieldtype-intl-phone.hs-input>select.hs-input{width:30%!important}}.hs-fieldtype-textarea.hs-input{resize:vertical}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 .hs-button{white-space:pre-wrap}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 .hs-richtext{word-break:break-word}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 fieldset{border:0;padding:0;margin:0;max-width:500px}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 fieldset.form-columns-1 .hs-input{width:95%}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 fieldset.form-columns-1 .input{margin-right:8px}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 fieldset.form-columns-1 input[type=checkbox],.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 fieldset.form-columns-1 input[type=radio]{width:auto}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 fieldset.form-columns-2 .hs-form-field{width:50%;float:left}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 fieldset.form-columns-2 .input{margin-right:8px}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 fieldset.form-columns-3 .hs-form-field{width:32.7%;float:left}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 fieldset.form-columns-3 .input{margin-right:8px}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 label.hs-hidden{visibility:hidden}.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 .hs-field-desc{width:100%}.hs-custom-style .hs-input,.hs-custom-style fieldset{max-width:100%}.hs-custom-style>div.form-columns-3 .hs-form-field,.hs-custom-style fieldset.form-columns-3 .hs-form-field{width:33.3%}.hs-custom-style>div>div:last-of-type .hs-input:not([type=checkbox]):not([type=radio]),.hs-custom-style fieldset>div:last-of-type .hs-input:not([type=checkbox]):not([type=radio]){width:100%;max-width:100%}.hs-custom-style>div input:not([type=image]):not([type=submit]):not([type=button]):not([type=radio]):not([type=checkbox]):not([type=file]),.hs-custom-style fieldset input:not([type=image]):not([type=submit]):not([type=button]):not([type=radio]):not([type=checkbox]):not([type=file]){box-sizing:border-box;padding:0 15px;min-height:27px}.hs-custom-style>div textarea,.hs-custom-style fieldset textarea{padding:10px 15px}.hs-custom-style .hs-dependent-field>div .hs-input:not([type=checkbox]):not([type=radio]){width:100%}@media (max-width:400px),(min-device-width:320px) and (max-device-width:480px){.hs-custom-style .hs-input:not([type=checkbox]):not([type=radio]),.hs-custom-style fieldset{margin-right:0!important;width:100%!important}form.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6:not(.hs-video-form) .form-columns-2 .hs-form-field,form.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6:not(.hs-video-form) .form-columns-3 .hs-form-field{float:none;width:100%}form.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6:not(.hs-video-form) .form-columns-2 .hs-form-field .hs-input,form.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6:not(.hs-video-form) .form-columns-3 .hs-form-field .hs-input{width:95%}form.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6:not(.hs-video-form) .form-columns-2 .hs-form-field input[type=checkbox],form.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6:not(.hs-video-form) .form-columns-2 .hs-form-field input[type=radio],form.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6:not(.hs-video-form) .form-columns-3 .hs-form-field input[type=checkbox],form.hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6:not(.hs-video-form) .form-columns-3 .hs-form-field input[type=radio]{width:auto}}.legal-consent-container .field.hs-form-field{margin-bottom:8px}.legal-consent-container .hs-field-desc.checkbox-desc{margin:-12px 0 0 21px}.legal-consent-container .hs-form-booleancheckbox-display input{float:left}.legal-consent-container .hs-form-booleancheckbox-display>span{display:block;margin-left:20px}.legal-consent-container .hs-form-booleancheckbox-display p{margin:0;display:inline}.legal-consent-container .hs-error-msgs label{color:#f2545b}.legal-consent-container~.hs_recaptcha{margin-top:18px}.cookie-reset-container{font-size:14px;margin-bottom:10px;text-align:right}#hs-outer-captcha-target,#hs-outer-captcha-target *{display:none;height:0;width:0}.hubspot-link__container{font-size:14px;padding-bottom:40px;position:relative;color:#9fa0a2;font-family:Helvetica Neue,Helvetica,Arial,sans-serif}.hubspot-link-text{color:#00a4bd;font-weight:400}.hubspot-link__container.sproket{color:#9fa0a2}.hubspot-link{color:#9fa0a2}.hubspot-link,.hubspot-link:hover{text-decoration:none}.hubspot-link:hover .hubspot-link-text{text-decoration:underline}.hubspot-link__icon{margin-bottom:-1px;margin-right:5px}.hubspot-link__container.sproket .hubspot-link__icon{width:30px;margin-right:0;float:left;margin-top:-9px;margin-left:-5px}</style></head>
    <body data-new-gr-c-s-check-loaded="14.1107.0" data-gr-ext-installed="">

        

<div class="sr-only">
    <p>Go To:</p>
    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#paper-title">Paper Title</a>
    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#paper-authors">Paper Authors</a>
    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#paper-toc">Table Of Contents</a>
    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#paper-abstract">Abstract</a>
    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#paper-references">References</a>
</div>

<header class="app__header">
    <div class="app__navigation">
        <a href="https://papertohtml.org/" class="button">Home</a>
        <a href="https://allenai.org/"><img src="./7617187_files/ai2.svg" alt="Allen Institute for AI" class="logo"></a>
    </div>

    <div class="settings" aria-hidden="true">
        <div class="dropdown">
            <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#" class="dropdown-toggler button" tabindex="-1" .="">Reading Aids</a>
            <div class="popover">
                <div class="options options--4">
                    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#" class="option js-aid on">None</a>
                    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#" class="option js-aid" data-aid="aid--dyslexia">Dyslexic Friendly</a>
                    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#" class="option js-aid" data-aid="aid--focused">Focus</a>
                    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#" class="option js-aid" data-aid="aid--xl">Extra Large</a>
                </div>
            </div>
        </div>
        
        <div class="dropdown">
            <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#" class="dropdown-toggler button" tabindex="-1" .="">Display Settings</a>
            <div class="popover">
                <div class="options">
                    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#" class="option js-themer on">Light</a>
                    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#" class="option js-themer" data-theme="theme--reversed">Dark</a>
                    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#" class="option js-themer" data-theme="theme--apple2">Retro</a>
                </div>
            </div>
        </div>
    </div>
</header>

<main class="app">

<!-- <div>
    <p><a href="/about">Learn more about this prototype</a></p>
<div> -->

<article class="paper">
    <div class="paper__head">
        
        <div>
            <a href="mailto:accessibility@semanticscholar.org?subject=[Paper%20To%20HTML]%20Problem%20with%20upload%20acbd601957c6381a71115a1309f461f3e480ebc7&amp;body=Please%20describe%20the%20main%20issues%20you%20encountered%20(optional):%0D%0A%0D%0A%0D%0ATo%20help%20us%20debug,%20please%20consider%20attaching%20the%20PDF%20or%20other%20file%20you%20uploaded.%20Note%20that%20Paper%20to%20HTML%20is%20designed%20primarily%20to%20handle%20scientific%20papers;%20if%20you%20are%20uploading%20a%20different%20type%20of%20document,%20performance%20may%20be%20poor.%0D%0A%0D%0ADebug:%0D%0Ahttps://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7">
                Report a problem with this paper
            </a>
        </div>
        <p> </p>
        <h1 class="paper__title" id="paper-title">Inclusion body myositis</h1>
        <!-- <form action="/download", method="GET">
            <button type="submit" name="id" value=acbd601957c6381a71115a1309f461f3e480ebc7> Download HTML </button>
        </form> -->
        <h2 class="sr-only" id="paper-authors">Authors</h2>
        <ul class="paper__meta">
             
                <li class="paper__meta-item"> 
                    
                R. Barohn</li> 
             
                <li class="paper__meta-item"> 
                    
                A. Amato</li> 
             
                <li class="paper__meta-item"> 
                    
                Z. Sahenk</li> 
             
                <li class="paper__meta-item"> 
                    
                J. Kissel</li> 
             
                <li class="paper__meta-item"> 
                    
                J. Mendell</li> 
            
            
                <li class="paper__meta-item"><i>Neurology</i></li>
            
            
                <li class="paper__meta-item">1995</li>
            
            
            
                <li class="paper__meta-item">
                    
                        <a href="https://semanticscholar.org/paper/acbd601957c6381a71115a1309f461f3e480ebc7" target="_blank">View in Semantic Scholar</a>
                    
                </li>
            
        </ul>

        <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#" aria-hidden="true" class="js-toc-toggle toc-toggle">Table Of Contents</a>
    </div>

    <nav class="paper__nav">
        <div class="paper__toc card">
            <!-- TOC -->
            <h2 id="paper-toc" class="toc__header">Table of Contents</h2>
            <ul>
                
                    <li><a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#paper-abstract">Abstract</a></li>
                
                
                <li>
                    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#section-body-1">SECTION</a>
                    
                    
                </li>
                
                <li>
                    <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#section-body-2">Discussion.</a>
                    
                    
                </li>
                
                <li><a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#paper-references">References</a></li>
            </ul>
        </div>
    </nav>

    <div class="paper__text">
        <!--Only show abstract if exists-->
        
            <h2 id="paper-abstract" tabindex="0"> Abstract </h2>
            <p tabindex="0"> We treated eight patients who had inclusion body myositis (IBM) with oral prednisone therapy, and we performed muscle biopsies before and after treatment. We documented the patients' clinical response to therapy and changes in serum CK. Although the serum CK level fell, muscle strength worsened after prednisone treatment. In addition, while inflammation decreased in the muscle biopsy specimens, the number of vacuolated and amyloid-positive fibers increased after oral prednisone therapy. These observations indicate that the inflammatory response in IBM may play a secondary role in the pathogenesis of IBM. The unique findings of intracellular amyloid deposits and rimmed vacuoles distinguishing IBM from other inflammatory myopathies, and recognition that suppression of inflammation has no effect on the clinical course, suggest that IBM may represent a degenerative muscle disorder.</p>
        

        <!-- Body text -->
        
            <h2 id="section-body-1" tabindex="0">SECTION </h2>
            
            
            
                
                    <p tabindex="0">The three major categories of inflammatory myopathy are polymyositis, dermatomyositis, and inclusion body myositis (IBM), with the latter accounting for at least 30% of inflammatory myopathy cases referred to a tertiary care center.' The histologic constellation of IBM consists of endomysial inflammation, rimmed vacuoles in muscle fibers, and the identification of 15to 18-nm filaments usually found in the cytoplasm and less oRen in the nucleus. Mendell et a12 identified intracellular (mostly cytoplasmic but also intranuclear) amyloid deposits in muscle fibers in IBM patients; apple-green birefringent deposits are visualized with polarization microscopy of Congo red-stained muscle of IBM patients. </p>
                
            
                
                    <p tabindex="0">A notable feature of IBM is the clinical progression of muscle weakness despite immunosuppressive therapy at doses adequate to treat dermatomyositis and polymyositis. These observations raise questions about the role of mononuclear cell invasion of muscle fibers in the relentless course of IBM. In eight patients with IBM treated for 6 to 24 months (table), we compared findings on repeat muscle biopsies with the clinical response and serum CK levels. </p>
                
            
                
                    <p tabindex="0">Methods. Eight patients fulfilled clinical and histologic criteria for 1BM.l All biopsies showed characteristic Congo red deposits typical of amyloid in the muscle biopsy specimens. Following diagnosis, all patients were treated with single, daily-dose prednisone 100 mglday for 4 weeks and then switched to alternate-day doses of 100 mg for at least 6 months (patients 1 and 8 for 24 months; patients 2, 3, and 6 for 12 months; patient 4 for 11 months; patient 7 for 8 months; patient 5 for 6 months). ARer this period of oral prednisone therapy, each patient was asked to undergo a repeat muscle biopsy and gave informed consent. The second biopsy specimen was obtained from the same muscle group as the first specimen but in the contralateral extremity. Patients were not receiving other immunosuppressive therapies during this period. </p>
                
            
                
                    <p tabindex="0">For all patients the average muscle score (AMS) was calculated3 using a modified Medical Research Council scale expanded to a 10-point system. In addition, functional disability scores were obtained: 0 = no functional problems; 1 = minor symptoms (capable of running); 2 = able to walk 30 feet with assistance but unable to run; 3 = able to walk 30 feet with assistance (walker or cane); 4 = able to walk less than 30 feet with assistance; 5 = wheelchair bound. AMS, functional score, and serum CK levels were obtained before and after prednisone therapy. </p>
                
            
                
                    <p tabindex="0">In pre-and post-treatment muscle biopsies, the area of each was determined in a hematoxylin and eosin (H-E)-stained section using a morphometric system previously described.2 A serial section was stained with Congo red. Results. Following prednisone therapy, serum CK levels declined in all eight patients; four fell into the normal range. No improvement was noted in AMS or functional disability score. In fact, AMS deteriorated in all eight patients and disability score deteriorated in one patient (table) . In all post-treatment muscle biopsy specimens, the number of non-necrotic muscle fibers with mononuclear cell invasion decreased (table). In contrast, the number of vacuolated and amyloid-positive fibers increased in all but one case (patient 3). </p>
                
            
        
            <h2 id="section-body-2" tabindex="0">Discussion. </h2>
            
            
            
                
                    <p tabindex="0">The results of this study demonstrate paradoxical observations. Despite suppression of mononuclear cell invasion of non-necrotic muscle fibers and decreased serum CK levels, muscle strength continued to deteriorate while patients were treated with prednisone therapy. The progressive muscle weakness was associated with an increased number of vacuolated muscle fibers and amyloid-positive fibers. Although the histologic changes in IBM are a multifocal p r o~e s s ,~ and while the second biopsy was done in a muscle from the contralateral limb, the findings following prednisone therapy clearly did not follow a random distribution. Cell infiltration declined in every prednisone-treated patient, while vacuoles and amyloidpositive fibers increased in all but one patient. These findings suggest that the inflammatory response is not solely accountable for the relentless course, because suppression of inflammation will not halt the progression of disease. An untreated control group for comparison or further documentation of the natural history would be necessary to define the degree of disability induced by inflammation alone. </p>
                
            
                
                    <p tabindex="0">Despite limitations, these findings emphasize the potential importance of the vacuolated fibers and amyloidogenic material in the underlying pathogenesis of muscle weakness. Some investigators have attempted to establish analogies between IBM and Alzheimer's disease (AD) because of the amyloid deposits. Askanas et a15 have shown that the amyloidogenic protein deposited in IBM is betaamyloid. In addition, the Nand C-terminal epitopes of amyloid precursor protein, ubiquitin, antichymotrypsin, apolipoprotein E, and hyperphosphorylated tau protein accumulate within the vacuolated muscle fibers of IBM.5-9 These same proteins are present within the senile plaques and neurofibrillary tangles i n t h e brains of AD patients. lo Co-localization studies for the presence of these proteins by electron microscopy has demonstrated that tau protein and ubiquitin are present on bundles of cytoplasmic tubulofilaments (15 to 18 nm) while beta-amyloid protein is exclusively localized to 6-to 10-nm filament^.^^^ The pathogenic mechanisms that produce the accumulation of this aberrant material in AD and IBM remain unknown. The potential similarities are, however, of interest since both disorders are relentlessly progressive. In addition, while most cases of AD and IBM are sporadic, autosomal dominant kindreds occur in both diseases. <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#BIBREF9" id="BIBREF9-Discussion.-ref">[11]</a> <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#BIBREF10" id="BIBREF10-Discussion.-ref">[12]</a> <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#BIBREF11" id="BIBREF11-Discussion.-ref">[13]</a> Rimmed vacuoles, 15to 18-nm tubulofilaments, and amyloid deposition are not specific for IBM and can be demonstrated in noninflammatory myopathies such as oculopharyngeal dystrophy14 and some forms of distal myopathy. <a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#BIBREF13" id="BIBREF13-Discussion.-ref">15</a> It remains difficult to account for the inflammatory response in IBM, which can reach rather florid proportions in some patients. Could it be secondary to the amyloidogenic material? Evidence suggests a lack of relationship, since a common observation is the failure to identify mononuclear cells invading amyloid-positive fibers. On the other hand, inflammation may be seen in muscular dystrophies such as Duchenne muscular dystrophy,16 facioscapulohumeral dystrophy, l7 and oculopharyngeal dystrophy,18 in which the inflammatory response represents a secondary phenomenon. A localized inflammatory reaction can also occur in the brain in AD.l0 </p>
                
            
                
                    <p tabindex="0">Despite the lack of current understanding of IBM, a series of recent ~b s e r v a t i o n s ,~~~-~J~ including those reported here, continues to emphasize the distinction among IBM, polymyositis, and dermatomyositis. This study again emphasizes that immunosuppressive therapy, in this case prednisone, is not clinically effective in the treatment of IBM. In this regard, we recently reported that IBM does not respond to IV immun~globulin,~~ although an earlier smaller series suggested a possible benefit.20 </p>
                
            
                
                    <p tabindex="0">On the other hand, IV immunoglobulin appears to be an effective therapy for dermatomyositis.21 The lack of response to immunosuppressive therapy in IBM, along with our histologic data and that of othe r~,~-~ suggests that progression of weakness in IBM cannot be explained on the basis of inflammation. More studies are needed to elucidate the pathogenesis of this distinctive myopathic disorder. </p>
                
            
        

        <footer>
            
                <h2 id="paper-references" tabindex="0">References</h2>
                <ul tabindex="0">
                    
                        <li id="BIBREF0">Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. In- clusion body myositis: observations in 40 patients. Brain Mendell JR, Sahenk Z, Gales T, Paul L. Amyloid filaments in inclusion body myositis: novel findings provide insight into nature of filaments. Arch Neurol 1991;48:1229-1234. Barohn RJ, Sahenk Z, Warmolts JR, Mendell JR. The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later. Arch Neurol 1991;48:1130-1135.</li>
                    
                        <li id="BIBREF1">Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demon- stration and counts of muscle fibers invaded by T cells. Ann Neurol 1984;16:193-208.</li>
                    
                        <li id="BIBREF10">Saunders AM, Strittmatter WJ, Schmechel D, et al. Associa- tion of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.<br><i><a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#BIBREF10-Discussion.-ref">Discussion.</a></i></li>
                    
                        <li id="BIBREF11">Neville HE, Baumbach LL, Ringel SP, Russo LS Jr, Sujan- sky E, Garcia CA. Familial inclusion body myositis: evidence for autosomal dominant inheritance. Neurology 1992;<br><i><a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#BIBREF11-Discussion.-ref">Discussion.</a></i></li>
                    
                        <li id="BIBREF12">Villanova M, Kawai M, Lubke U, et al. Rimmed vacuoles of inclusion body myositis and oculopharyngeal dystrophy con- tain amyloid precursor protein and lysosomal markers. Brain Res 1993;603:343-347.</li>
                    
                        <li id="BIBREF13">Barohn RJ. Distal myopathies and dystrophies. Semin Neu- rol 1993;13:247-255.<br><i><a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#BIBREF13-Discussion.-ref">Discussion.</a></i></li>
                    
                        <li id="BIBREF14">Kissel JT, Burrow KL, Rammohan KW, Mendell JR, and the CIDD Study Group. Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. Neurology 1991;41:667-672.</li>
                    
                        <li id="BIBREF15">Munsat TL, Piper D, Cancilla P, et al. Inflammatory myopa- thy with facioscapulohumeral distribution. Neurology 1972;</li>
                    
                        <li id="BIBREF16">Bosch PE, Gowans JDC, Munsat T. Inflammatory myopathy in oculopharyngeal dystrophy. Muscle Nerve 1979;2:73-77.</li>
                    
                        <li id="BIBREF17">Amato AA, Barohn RJ, Jackson CE, Pappert EJ, Sahenk Z, Kissel JT. Inclusion body myositis: treatment with intra- venous immunoglobulin. Neurology 1994;441516-1518.</li>
                    
                        <li id="BIBREF18">Soueidan SA, Dalakas MC. Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin. Neu- rology 1993;43:876-879.</li>
                    
                        <li id="BIBREF19">Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329: 144:177-187. ogy 1993;43(s~ppl4):S24-S38.</li>
                    
                        <li id="BIBREF2">Askanas V, Alvarez RB, Engel WK. Beta-amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann Neurol 1993;34:551-560.</li>
                    
                        <li id="BIBREF3">Askanas V, Serdaroglu P, Engel WK, Alvarez RB. Im- munolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy. Neurosci Lett 1991;10:73-76. 1989; 112~727-747.</li>
                    
                        <li id="BIBREF5">Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am J Pathol 1994;</li>
                    
                        <li id="BIBREF6">Askanas V, Engel WK. New advances in inclusion-body myositis. Curr Opin Rheumatol 1993;5:732-741.</li>
                    
                        <li id="BIBREF7">Askanas V, Mirabella M, Engel WK, Alvarez RB. Apolipo- protein E immunoreactive deposits in inclusion-body muscle diseases. Lancet 1994;343:364-365.</li>
                    
                        <li id="BIBREF8">Blass JP. Pathophysiology of Alzheimer's syndrome. Neurol-</li>
                    
                        <li id="BIBREF9">Schellenberg GD, Bird TD, Wijsman EM, et al. Genetic link- age evidence for a familial Alzheimer's disease locus on chro- mosome 14. Science 1992;258:668-671.<br><i><a href="https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7#BIBREF9-Discussion.-ref">Discussion.</a></i></li>
                    
                </ul>
            
        </footer>
    </div>
</article>
</main>


        <footer class="app__footer">

            <div class="app__signup-form">
                <!--[if lte IE 8]>
                   <script charset="utf-8" type="text/javascript" src="//js.hsforms.net/forms/v2-legacy.js"></script>
                <![endif]-->
                <script type="text/javascript" async="" src="./7617187_files/heap-2424575119.js"></script><script charset="utf-8" type="text/javascript" src="./7617187_files/v2.js"></script>
                <script data-hubspot-rendered="true">
                    hbspt.forms.create({
                        region: "na1",
                        portalId: "5910970",
                        formId: "05456229-75ba-4c85-99c0-33e2cbe8d1df"
                    });
                </script><div id="hbspt-form-33ec6275-a4b0-42c9-ba90-c715833d99c6" class="hbspt-form" data-hs-forms-root="true"><form id="hsForm_05456229-75ba-4c85-99c0-33e2cbe8d1df" method="POST" accept-charset="UTF-8" enctype="multipart/form-data" novalidate="" action="https://forms.hsforms.com/submissions/v3/public/submit/formsnext/multipart/5910970/05456229-75ba-4c85-99c0-33e2cbe8d1df" class="hs-form-private hsForm_05456229-75ba-4c85-99c0-33e2cbe8d1df hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df hs-form-05456229-75ba-4c85-99c0-33e2cbe8d1df_33ec6275-a4b0-42c9-ba90-c715833d99c6 hs-form stacked" target="target_iframe_05456229-75ba-4c85-99c0-33e2cbe8d1df" data-instance-id="33ec6275-a4b0-42c9-ba90-c715833d99c6" data-form-id="05456229-75ba-4c85-99c0-33e2cbe8d1df" data-portal-id="5910970"><div class="hs_email hs-email hs-fieldtype-text field hs-form-field"><label id="label-email-05456229-75ba-4c85-99c0-33e2cbe8d1df" class="" placeholder="Enter your Join our accessibility mailing list to receive updates on research and prototypes" for="email-05456229-75ba-4c85-99c0-33e2cbe8d1df"><span>Join our accessibility mailing list to receive updates on research and prototypes</span></label><legend class="hs-field-desc" style="display: none;"></legend><div class="input"><input id="email-05456229-75ba-4c85-99c0-33e2cbe8d1df" name="email" placeholder="" type="email" class="hs-input" inputmode="email" autocomplete="email" value=""></div></div><div class="hs_submit hs-submit"><div class="hs-field-desc" style="display: none;"></div><div class="actions"><input type="submit" class="hs-button primary large" value="Submit"></div></div><input name="hs_context" type="hidden" value="{&quot;embedAtTimestamp&quot;:&quot;1683089414559&quot;,&quot;formDefinitionUpdatedAt&quot;:&quot;1665163279690&quot;,&quot;lang&quot;:&quot;en&quot;,&quot;embedType&quot;:&quot;REGULAR&quot;,&quot;notifyHubSpotOwner&quot;:&quot;true&quot;,&quot;renderRawHtml&quot;:&quot;true&quot;,&quot;userAgent&quot;:&quot;Mozilla/5.0 (Macintosh; Intel Mac OS X 10_15_7) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/112.0.0.0 Safari/537.36&quot;,&quot;pageTitle&quot;:&quot;Inclusion body myositis | Paper to HTML | Allen Institute for AI&quot;,&quot;pageUrl&quot;:&quot;https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7&quot;,&quot;urlParams&quot;:{&quot;id&quot;:&quot;acbd601957c6381a71115a1309f461f3e480ebc7&quot;},&quot;isHubSpotCmsGeneratedPage&quot;:false,&quot;formTarget&quot;:&quot;#hbspt-form-33ec6275-a4b0-42c9-ba90-c715833d99c6&quot;,&quot;locale&quot;:&quot;en&quot;,&quot;timestamp&quot;:1683089414516,&quot;originalEmbedContext&quot;:{&quot;portalId&quot;:&quot;5910970&quot;,&quot;formId&quot;:&quot;05456229-75ba-4c85-99c0-33e2cbe8d1df&quot;,&quot;region&quot;:&quot;na1&quot;,&quot;target&quot;:&quot;#hbspt-form-33ec6275-a4b0-42c9-ba90-c715833d99c6&quot;,&quot;isBuilder&quot;:false,&quot;isTestPage&quot;:false,&quot;isPreview&quot;:false,&quot;isMobileResponsive&quot;:true},&quot;correlationId&quot;:&quot;33ec6275-a4b0-42c9-ba90-c715833d99c6&quot;,&quot;renderedFieldsIds&quot;:[&quot;email&quot;],&quot;captchaStatus&quot;:&quot;NOT_APPLICABLE&quot;,&quot;emailResubscribeStatus&quot;:&quot;NOT_APPLICABLE&quot;,&quot;isInsideCrossOriginFrame&quot;:false,&quot;source&quot;:&quot;forms-embed-1.3102&quot;,&quot;sourceName&quot;:&quot;forms-embed&quot;,&quot;sourceVersion&quot;:&quot;1.3102&quot;,&quot;sourceVersionMajor&quot;:&quot;1&quot;,&quot;sourceVersionMinor&quot;:&quot;3102&quot;,&quot;_debug_allPageIds&quot;:{},&quot;_debug_embedLogLines&quot;:[{&quot;clientTimestamp&quot;:1683089414512,&quot;level&quot;:&quot;INFO&quot;,&quot;message&quot;:&quot;Retrieved pageContext values which may be overriden by the embed context: {\&quot;pageTitle\&quot;:\&quot;Inclusion body myositis | Paper to HTML | Allen Institute for AI\&quot;,\&quot;pageUrl\&quot;:\&quot;https://papertohtml.org/paper?id=acbd601957c6381a71115a1309f461f3e480ebc7\&quot;,\&quot;userAgent\&quot;:\&quot;Mozilla/5.0 (Macintosh; Intel Mac OS X 10_15_7) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/112.0.0.0 Safari/537.36\&quot;,\&quot;urlParams\&quot;:{\&quot;id\&quot;:\&quot;acbd601957c6381a71115a1309f461f3e480ebc7\&quot;},\&quot;isHubSpotCmsGeneratedPage\&quot;:false}&quot;},{&quot;clientTimestamp&quot;:1683089414514,&quot;level&quot;:&quot;INFO&quot;,&quot;message&quot;:&quot;Retrieved countryCode property from normalized embed definition response: \&quot;US\&quot;&quot;}]}"><iframe name="target_iframe_05456229-75ba-4c85-99c0-33e2cbe8d1df" style="display: none;" src="./7617187_files/saved_resource.html"></iframe></form></div>
            </div>

            <div class="content text-center">
                © <a href="https://allenai.org/">The Allen Institute for Artificial Intelligence (AI2)</a> - All Rights Reserved<br>
                <a href="https://allenai.org/privacy-policy.html">Privacy Policy</a>
                | <a href="https://allenai.org/terms.html">Terms of Use</a>
            </div>
        </footer>
        <script src="./7617187_files/init.min.js" data-app-name="a11y2" async=""></script>
        <script src="./7617187_files/jquery.min.js"></script>
        <script src="./7617187_files/a11y.js"></script>
        
        <script type="text/javascript">
            window.heap=window.heap||[],heap.load=function(e,t){window.heap.appid=e,window.heap.config=t=t||{};var r=t.forceSSL||"https:"===document.location.protocol,a=document.createElement("script");a.type="text/javascript",a.async=!0,a.src=(r?"https:":"http:")+"//cdn.heapanalytics.com/js/heap-"+e+".js";var n=document.getElementsByTagName("script")[0];n.parentNode.insertBefore(a,n);for(var o=function(e){return function(){heap.push([e].concat(Array.prototype.slice.call(arguments,0)))}},p=["addEventProperties","addUserProperties","clearEventProperties","identify","removeEventProperty","setEventProperties","track","unsetEventProperty"],c=0;c<p.length;c++)heap[p[c]]=o(p[c])};
            heap.load("2424575119");
        </script>
        
    
<script src="./7617187_files/count.js" data-goatcounter="https://a11y2.stats.allenai.org/count" async=""></script></body><grammarly-desktop-integration data-grammarly-shadow-root="true"><template shadowrootmode="open"><style>
  div.grammarly-desktop-integration {
    position: absolute;
    width: 1px;
    height: 1px;
    padding: 0;
    margin: -1px;
    overflow: hidden;
    clip: rect(0, 0, 0, 0);
    white-space: nowrap;
    border: 0;
    -moz-user-select: none;
    -webkit-user-select: none;
    -ms-user-select:none;
    user-select:none;
  }

  div.grammarly-desktop-integration:before {
    content: attr(data-content);
  }
</style><div aria-label="grammarly-integration" role="group" tabindex="-1" class="grammarly-desktop-integration" data-content="{&quot;mode&quot;:&quot;full&quot;,&quot;isActive&quot;:true,&quot;isUserDisabled&quot;:false}"></div></template></grammarly-desktop-integration></html>